ANTIANXIETY PROPERTY OF BASELLA ALBA LINN LEAVES EXTRACT IN EXPERIMENTAL ANIMALS - BIBLIOGRAPHY
9. BIBLIOGRAPHY
1.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR,
Walters EE. Arch Gen Psychiatry 2005; 62: 593–602.
2.
Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN,
Berndt ER, Davidson JR. JClin Psychiatry 1990; 60: 427–435.
3.
Prevalence
of Phobias in the United State.
Available from: http://www.phobias.about.com/od/prevalence/a/phobprevus
4.
Rang HP, Dale MM, Ritter JM,
5.
Kunovac JL
and Stahl
SM. Future
directions in anxiolytic pharmacotherapy. Psychiatry. Clin. North Am 1995; 18: 895–909.
6.
Ernst E. Herbal remedies for
anxiety – a systematic review of controlled clinical trials, Phytomedicine
2006; 13: 205–208.
7.
Goodman and Gilman's. The
Pharmacological Basis of Therapeutics. The
8.
Longo,
LP, Johnson B. Addiction: Part I. Benzodiazepines: Side effects, abuse risk and
alternatives. American Family
Physician 2000; 61: 2121-2128.
9.
Lader
MH. Limitations on the use of benzodiazepines in anxiety and insomnia are they
justified. European
Neuropsychopharmacology1999; 9 (Suppl6): S399-S404.
10.
Rickels
K, Case WG, Downing RW, Winokur A. Long-term diazepam therapy and clinical
outcome. Journal of American Medical
Association 1983; 250: 767-771.
11.
Woods
JH, Katz JL, Winger G. Abuse liabilities of benzodiazepines. Pharmacology Reviews 1987; 39:
251-413.
12.
Ashton
H. Benzodiazepine withdrawal an unfinished story. British Medical Journal 1984; 288: 1135-40.
13.
Busto
U, Sellers EM, Naranjo CA, Cappell HP, Sanchez CM, Sykora K. Withdrawal
reaction after long-term therapeutic use of benzodiazepines.
- Lance P. Longo, Brian Johnson. Addiction: Part
I Benzodiazepines Side Effects,
Abuse Risk and Alternatives. Am Fam Physician 2000 ;
61(7): 2121-2128.
15.
Palva ES, Linnoila M, Saario I, Mattila M. Acute and subacute effects of diazepam on psychomotor skillsm, interactions with alcohol. Acta
pharmacol Toxicol 1979; 45:257-264.)
16.
Importance of Medicinal plants, http;//www.ayuvedaherbs.wordpress.com
17.
Steve Blake. Medicinal Plant Actions. Excerpts from the full book: Medicinal Plants Starting
with C and D. URL: http://www.NaturalHealthWizards.com
18.
Inamdar Nazma, Esalat Shima,
Kotwal VB, Pawar Sunita. Herbal drugs in milieu of modern drugs. International
Journal of green pharmacy 2008; 2 (1): p.2-8.
19.
Larner and Brody. Brody’s Human
Pharmacology. Molecular to Clinical. 4th edition; 2005: p.305.
20.
Kamaldeep Dhawan, Suresh kumar
and Anupam Sharma. Anti-anxiety studies on extracts of Pssiflora incarnate Linn. Journal of Ethnopharmacology 2001;
78(2-3): 165-170.
21.
The Merck Index. Monograph
No-2278, 13th edition, 391p.
22.
Sankara S, Subramanium,
Nagarjan S, Sulochana N. Chrysin 7- rutinoside from the leaves of Dolichandrone
falcata, Phytochemistry 1972; 2(1): 438-439.
23.
Suresh Babu K, Hari Babu T,
Srinivas PV, Harakishor K, Murty USN, Madhusudanaa Rao J. Synthesis and
biological evaluation of novel C(7) modified chrycin analogues as antibacterial
agents.Bioorganic and medicinal chemistry latters 2006;16: 221-224.
24.
Kumar V. Potential Medicinal
Plants for CNS Disorders: an Overview. Phytother. Res 2006;
20: 1023–1035.
25.
Anguirre-hernandez E,
Gonzalez-trujano ME, Martinez AL, Moreno J, Kite G, Terrazas T, et al. HPLC/MS
analysis and anxiolytic-like effect of quercetin and kaempferol flavonoids from
Tilia Americana var. mexicana. Journal of ethanopharmacology
2010 Jan 8;127(1):91-97.
26.
Herrara-ruiz M, Roman-ramos R,
Zamilpa A, Tortoriello J, Jimenez-ferrer JE. Flavonoids from Tilia Americana with anxiolytic activity
in plus-maze test. Journal of ethanopharmacology 2008 Jul 23;118(2):312-317.
27.
De Almeida ER, Xavier HS,
Chaves TM, Couto GBL, Aragao-Neto AC, Silva AR, et al. Anxiolytic and
anticonvulsant effects of dioclenol flavonoid isolated from stem bark of dioclea grandiflora on mice.
International journal of applied research in natural products 2009 Dec-2010
Jan;2(4):44-51.
28.
Coleta M, Batista MT, Campos
MG, Carvalho R, Cotrim MD, M. de lima TC, et al. Neuropharmacological
Evaluation of the putative anxiolytic effects of Passiflora edulis sims, its sub-fractions and flavonoid
constituents. Phytotherapy research 2006 Sep 28;20:1067-1073.
29.
Wolfman C, Viola H, Dasjas F,
Medina JH. Possible anxiolytic effects
of chrysin, a central benzodiazepine receptor ligand isolated from passiflora
coerulea. Pharmacol biochem behave. 1994 Jan;47(1):1-4.
30.
Anandarajagopal K, Sudhahar D,
Ajaykumar TV, Muthukumar G. Evaluation of CNS depressant activity of aerial
parts of Basella alba Linn. IJPI’s
Journal of Pharmacology and Toxicology 2011;1(5):1-6.
31.
Reshmi SK, Aravinthan KM,
Suganyad devi P. Antioxidant analysis of betacycnin extracted from Basella alba fruit. International
Journal of PharmaTech research 2012 jul-sep;4(3):900-913.
32.
Yang RY, lin S, kuo G. Content
and distribution of flavonoids among 91 edible plant species. Asia Pac J Clin
Nutr 2008;17(S1):275-279.
33.
Grundmann O, Nakajima J, Kamata
K, Seo S, Butterweck V. Kampferol from the leaves of apocynum venetum possesses
anxiolytic activities in the elevated plus maze test in mice. Phytomedicine
2009 Apr;16(4):295-302.
34.
Basella alba Linn. [online]. [cited on 2013 Feb
25]; Available from: http://en.wikipedia.org/wiki/Basella_alba.
35.
Mohapatra
SP, Sahoo HP. An ethno-medico-botanical study of bolangir, Orissa, India:
Native plant remedies against gynaecological diseases. Ethnobotanical leaflets
2008;12:846-850.
36.
Olowokudejo
JD, Kadiri AB, Travih VA. An ethnobotanical survey of herbal markets and
medicinal plants in lagos state of Nigeria. Ethnobotanical leaflets
2008;12:851-865.
37.
Titanji
VPK, Zofou D, Ngemenya MS. The antimalarial potential of medicinal plants used
for the treatment of malaria in Cameroonian folk medicine. Afr. J. Traditional,
complementary and alternative medicines 2008;5(3):302-321.
38.
Bamidele O,
Akinnuga AM, Olorunfemi JO, Odetola OA, Oparaji CK, Ezeigbo N. Effects of
aqueous extract of Basella alba leaves
on haematological and biochemical parameters in albino rats. African journal of
biotechnology 2010 Oct 11;9(41):6952-6955.
39.
Kuete V,
Efferth T. Cameroonian medicinal plants: pharmacology and derived natural
products. Frontiers in Pharmacology 2010 Oct 25;1:123.
40.
Chaitanya
KB. Anti inflammatory activity of Basella
alba Linn. in albino rats. Journal of Applied Pharmaceutical Science
2012;2(4):87-89.
41.
Moundipa PF, Beboy NSB, Zelefack F, Ngouela S,
Tsamo E, Schill WB, et al. Effects of Basella
alba and Hibiscus macranthus extracts
on testosterone production of adult rat and bull ley dig cells. Asian journal
of andrology 2005 Dec;7(4):411-417.
42.
Kumar V,
Bhat ZA, Kumar D, Khan NA, Chashoo IA, Ara I. Gastroprotective effect of leaf
extracts of Basella alba var. alba against experimental gastric ulcers
in rats. Brazilian Journal of Pharmacognosy
2012 May/Jun;22(3):657-662.
43.
Murray
MT. Quercetin nature’s antihistamine. Better Nutrition
1998.
44.
45.
Williams RJ, Spencer JPE,
Rice-Evans C. Serial review: Flavonoids and isoflavonones (Phytoestrogens)
Absorption, Metabolism and Bioactivity. Free Radical Biology and Medicine 2004;
36: 838-849.
46.
Tsuchiya H. Structure-dependent
membrane interaction of flavonoids associated with their bioactivity. Food
Chemistry 2010; 120: 1089-1096.
47.
Chebil L, Humeau C, Falcimaigne
A, Engasser J, Ghoul M. Enzymatic acylation of flavonoids. Process Biochemistry
2006; 41: 2237-2251.
48.
Middleton EJR, Kandaswami C,
Theoharides TC. The Effects of Plant Flavonoids on Mammalian cells, implications
for inflammation, heart disease, and cancer. Pharmacological Reviews 2000; 52:
673-751.
49.
Narayana KR, Reddy SR,
Chaluvadi MR, Krishna DR. Bioflavonoid classification, pharmacological,
biochemical effects and therapeutic potential. Indian Journal of Pharmacology
2001; 33: 2-16.
50.
Kumar P.
INDIAN SPINACH, Basella alba (PUI) succulent, branched, smooth, twining
herbaceous vine. Best Nutrition, 2010
51.
Yang RY,
Lin S, Kuo G. Content and distribution of flavonoids among 91 edible plant
species. Asia Pac J Clin Nutr. 2008; 17(S1): 275-279.
52.
Toshiyuki
M, Kazuhiro H, Masayuki Y. Medicinal foodstuffs. XXIII. Structures of new
oleananetype triterpene oligoglycosides, basellasaponins A, B, C, and D, from
the fresh aerial parts of Basella rubra L. Chem Pharm Bull. 2001;
49:776-779.
53.
Khare CP.
Indian medicinal plants: an illustrated dictionary. USA: Springer Science
Business Media, 2007.
54.
Maisuthisakul
P, Ritthiruangdej PS. Relationship between antioxidant properties and chemical
composition of some Thai plants. J Food Compos Anal. 2008; 21:229-240.
55.
Glassgen
WE, Metzger JW, Heuer S, Strack D. Betacyanins from fruits of Basella rubra.
Phytochemistry 1993; 33:1525-1527.
56.
Palanuvej
C, Hokputsa S, Tunsaringkarn T, Ruangrungsi N. In vitro glucose
entrapment and alpha-glucosidase inhibition of mucilaginous substances from
selected Thai medicinal plants. Sci Pharm. 2009; 77:837-849.
57.
Haq QN,
Awal A, Chowdhury MK, Khan NA. Water-soluble polysaccharides from the leaves of
Basella rubra. Sci Res. 1969; 6:63-6.
58.
Jani GK,
Shah DP, Jain VC, Patel MJ, Vithalani DA. Evaluating mucilage from Aloe
Barbadensis Miller as a pharmaceutical excipient for sustained release
matrix tablets. Pharm Technol. 2007; 31:90-98.
59.
Olajire AA,
Azeez L. Total antioxidant activity, phenolic, flavonoid and ascorbic acid
contents of Nigerian vegetables, African Journal of Food Science and
Technology 2011; 2(2): 022-029.
60.
Barbosa-Filho
JM, Alencar AA, Nunes XP, Tomaz ACA, Sena-Filho JG, Athayde-Filho PF, Silva MS,
Souza MFV, da-Cunha EVL. Sources of alpha-, beta-, gamma-, delta- and
epsilon-carotenes: A twentieth century review, Brazilian Journal of
Pharmacognosy 2008; 18(1): 135-154.
61.
Schmidt DR,
MacDonald HA, Brockman FE. Oxalate and Nitrate Contents of Four Tropical Leafy
Vegetables Grown at Two Soil Fertility Levels. Agronomy Journal 1970;
63(4): 559-561.
62.
Roshan
Adhikari, Naveen Kumar HN, Shruthi SD. A Review on Medicinal Importance of Basella
alba L. 2012;4(2):110-114.
63.
Basella alba Linn. [online].; Available from: http://mariekesjournal.blogspot.in/2010/04/mariekes-diary.html
64.
Karan Sharma, Narendra Kumar,
Kirandeep Raj, Junaid Niazi, Vikas Gupa. Anti anxiety activity of Eriobotrya japonica leaf extracts. Research
Journal of Pharmaceutical, Bilogical and Chemical Sciences 2011; 2(1):255-259.
65.
Habibur Rahman, A. Elumalai M.
Chinna Eswaraiah and Dipankar Bardalai.
Evaluation of anxiolytic activity of pisonia grandis R. Br leaves in mice.
Journal of Chemical and Pharmaceutical Research 2011;3(5):646-652.
66.
Sathish Kumar, P. Amudha, C.
Satheesh Kannan. Evaluation of anxiolytic activity of hydroalcoholic extract of
teprosia purpuria (L) pers on swiss
alwino mice. Internatinal Journal of Pharmaceutical Sciences Research
2011;2(5):1262-1269.
67.
Navdeep Singh, Sarabjit Kaur,
Bedi PMS, Divneer kaur. Anxiolytic effect of Equisetum arvense Linn. Extracts in mice. Indian Journal of
Experimental Biology 2011; 49:352-356.
68.
Sudhakar Pemminati,
Gopalakrishna HN, Venkatesh.V, Amritha Raj, Sowjanya Shetty, Amrita Vinod,
Bethi Yugandhar, Ashok K Shenoy. Anxiolytic effect of acute administration of
ursolic acid in rats. Research Journal of Pharmaceutical, Biological, and
Chemical Sciences 2011; 2(3):431-437.
69.
Gadekar Dayanand H, Jain
Sourabh, Malik Jitender K. Evaluation of anxiolytic activity of Boerhaavia diffusa hydroalcoholic
extract of leaves in rats. International Research Journal of Pharmacy 2011; 2(10):90-92.
70.
Habibur Rahman P, Murlidharan
D, Sivaraman Kartika B, Dipankar Saha. Evaluation of anxiolytic activity of
ethanolic extracts from the leaves of Trichosanthes
cucumerina L. in mice. Pelagia Research Library, Der Pharmacia sinica 2010;
1(3):86-94.
71.
Pitsikas N, Boultadakis A,
Georgiadou G, Tarantilis PA, Sakellaridis N. Effect of the active constituent
of Crocus sativus L., crocins, in an
animal model of anxiety. Phytomedicine 2008; 15: 1135-1139.
72.
Wei Xiu-Yan, Yang Jing-Yu, Wang
Jin-Hui, Wu Chun-Fu. Anxiolytic effect of saponins from Panax quinquefolium in mice. Journal of Ethnopharmacology 2007;
111: 613-618.
73.
Wijeweera P, Arnason JT,
Koszycki D, Merali Z. Evaluation of anxiolytic properties of Gotukola- (Centella asiatica) extracts and
asiaticoside in rat behavioral models. Phytomedicine 2006; 13: 668-676.
74.
Rabbani
M, Sajjadi SE, Zarei HR. Anxiolytic effect of Stachys lavandulifolia Vahl on the
elevated plus maze model in mice. Journal of Ethnopharmacology. 2003; 89:
271-276.
75.
Leite JR, Seabra ML, Maluf E,
Assolant K, Suchecki D, Tufik S, Klepacz S. Pharmacology of lemongrass (Cymbopogon citratus Stapf.) III.
Assessment of eventual toxic, hypnotic and anxiolytic effects on humans.
Journal of Ethnopharmacology 1986; 17: 75–83.
76.
Akhondzadeh S, Naghavi HR,
Vazirian M. Passionflower in the treatment of generalized anxiety a pilot
double-blind randomized controlled trials with oxazepam. J Clin Pharm Ther
2001; 26: 363–367.
77.
Borner
Jon, Andreson LA, Philipson JD. Herbal medicine. 2nd
ed; p.250:253.
78.
Ji
79.
Vandenbogaerde A, Zanoli P,
Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M. Evidence
That Total Extract of Hypericum perforatum Affects Exploratory
Behavior and Exerts Anxiolytic Effects in Rats. Pharmacology Biochemistry and
Behavior 2000; 65(4): 627–633.
80.
Masoumeh
Emamghoreishi, Mohammad Khasaki, Maryam Fath Aazam.
Coriandrum sativum Evaluation of its anxiolytic
effect in the elevated plus-maze. Journal of Ethnopharmacology 2005; 96:
365–370.
81.
Helli On-Ibarrola MC, Ibarrola
DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzano M, Tortoriello J, Fern
andez S, Wasowski C, Marder M, De Limad TCM, Mora S. The anxiolytic-like
effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. Journal of Ethnopharmacology 2006;
105: 400–408.
82.
Oliver Grundmanna,
Jun-IchiroNakajimab, KazuakiKamatab, ShujiroSeob, Veronika Butterweck.
Kaempferol fromtheleaves of Apocynum
venetum possesses anxiolytic activities in the elevated plus maze test in
mice. Phytomedicine 2009; 16: 295–302.
83.
Maribel
Herrera-Ruiz, Ruben Roman-Ramos, Alejandro Zamilpa, Jaime Tortoriello, Enrique
Jimenez-Ferrer J. Flavonoids from Tilia
84.
Fabiana Cardoso Vilela, Roseli Soncini, Alexandre Giusti-Paiva. Anxiolytic-like effect of Sonchus oleraceus L. in mice. Journal of Ethno pharmacology 2009; 124: 325–327.
85.
Thongsaard W, Deachapunya C,
Pongsakorn S, Boyd EA, Bennett GW, Marsden CA. A Potential Anxiolytic Extracted From Cassia siamea. Pharmacology
Biochemistry and Behavior 1996; 53(3): 753-758.
86.
Hongwei Li,
Peng Zhou, Qiqi Yang, Yan Shen, Jun Deng Li, De Zhao. Comparative
studies on anxiolytic activities and flavonoid compositions of Passiflora edulis ‘edulis’ and Passiflora edulis ‘flavicarpa. Journal of Ethnopharmacology 2011; 133: 1085–1090.
87.
Khalid Saifuddin, Kature
Dattatraya, Suresh DK, Shaikh KB, Gopalakrishna CH, Loya PJ. An anxiolytic
effect of Dolichandrone falcata leaves
extract in experimental animals. RJPBCS 2010; 1(3):524.
88.
Altaf
Ali, Venkat Rao N, Md. Shalam, Shivaraj Gouda T, Jeevan Mane Babu, Shantakumar
SM. Anxiolytic Activity of Seed Extract of Caesalpinia Bonducella (Roxb) In
Laboratory Animals. The Internet Journal of Pharmacology 2008; 5: 2.
89.
Ayoka AO, Akomolafe RO, Iwalewa
EO and Ukponmwan. Studies on the anxiolytic effect of Spondias mombin L. (Anacardiaceae) extracts. Afr. J. Trad. CAM
2005; 2(2):153-156.
90.
Shah Gagan, Shri Richa, Mann
Avninder. Rahar Sandeep, Panchal Vivek. Anxiolytic effects of Eleacarpus
sphaericus fruits on elevated plus maze model of anxiety in mice. International
Journal of PharmTech Research 2010; 2(3):1781-1786.
91.
Chandana C Barua, Jayanti D Roy,
Bhaben Buragohain, Achinta G Barua, Prabodh Borah, Mangala Lahkar. Anxiolytic
effect of hydroethanolic extract of Drymaria cordata L. Willd. Indian Journal
of Experimental Biology 2009;47:969-973.
92.
Richa Shri, Manjeet Singh,
Anupam Sharma. Bioactivity-directed separation of an anxiolytic fraction from
Aethusa cynapium L Journal of Pharmacognosy and Phytotherapy 2010;2(2):17-23.
93.
Avijit Chakraborty, Amudha P,
Geetha M, Srjit Singh N. Evaluation of anxiolytic activity of methanolic extract
of Sapindus mukorossi Gaertn in mice.
International Journal of Pharma and Bio Sciences 2010; 1(3):1-8.
94.
Akindele AJ, Adeyemi OO.
Anxiolytic and sedative effects of Byrsocapus
coccineus Schum Thonn. (Connaraceae) extract. International Journal of
Applied Research in Natural Products 2010; 3(1):28-36.
95.
Reecha Mdaan, Anupam Sharma.
Evaluation of anti-anxiety activity of Actaea
spicata Linn. International Journal of Pharmaceutical Sciences and research
2011; 3(1):45-47.
96.
Kaplan HI and Sadock BJ.
Synopsis of psychiatry. Baltimore: 8th ed. Williams and Wilkins.
1998. p.591.
97.
American Psychiatric
Association. Diagnostic and statistical manual for mental disorders 4thedition,
text revision. DC American Psychiatric Association, Washington; 2000.
98.
99.
Chavira DA,
100.
Verduin TL, Kendall PC.
Differential occurrence of comorbidity within childhood anxiety disorders.
Journal of Clinical Child and Adolescent Psychology 2003; 32: 290−295.
101.
Douglass HM, Moffit TE, Dar R,
McGee R. Obsessive compulsive disorder in a birth cohort of 18 year olds:
Prevalence and predictors. Journal of the American Academy of Child and
Adolescent Psychiatry 1995; 34: 1424−1431.
102.
Kovacs M, Devlin B.
Internalizing disorders in childhood. Journal of Clinical Psychology and
Psychiatry 1998; 39: 47−63.
103.
Anderson JC, Ollendick TH, King
NJ, Yule W. Epidemiological issues. International handbook of phobic and
anxiety disorders in children.
104.
Weems CF, Stickle TR. Anxiety
disorders in childhood: Casting a nomological net. Clinical Child and Family
Psychology Review 2005; 8: 107−134.
105.
Hettema JM, Neale MC, Kendler
KS. A review and meta-analysis of the genetic epidemiology of anxiety
disorders. American Journal of Psychiatry 2001; 158: 1568−1578.
106.
National Institute of Mental
Health. (1999, August) publicat/anxresfact.cfm (NIH Publication No. 99-4504).
Anxiety disorders research at the National Institute of Mental Health.
Retrieved August 3, 2006. Available from: http://www.nimh.nih.gov/
107.
Rauch SL, Shin LM, and Wright
CI. Neuroimaging studies of amygdala function in anxiety disorders. Annals of
the New York Academy of Sciences, 2003; 985: p.389−410.
108.
Millan MJ. The neurobiology and
control of anxious states. Progress in Neurobiology 2003; 70: p.83−244.
109.
Wolpe J. Psychotherapy by
reciprocal inhibition. Stanford, CA: Stanford University Press 1958.
110.
Mowrer OH. On the dual nature
of learning: A re-interpretation of “conditioning” and “problem-solving”.
Progress in Neurobiology 1947; 42: p.3−32.
111.
Rachman S. Fear of
contamination behaviour. Research and Therapy 2004; 42: 1227−1255.
112.
Murachver T, Pipe ME, Gordon R,
Owens JL, Fivush R. Do show and tell Children's event memories acquired through
direct experience, observation, and stories. Child Development 1996; 67: p.3029−3044.
113.
Elizabeth J, King N, Ollendick
TH, Gullone E, Tonge B, Watson S. Social anxiety disorder in children and youth:
A research update on aetiological factors. Counselling Psychology Quarterly.
2006; 19: 151−163.
114.
Muris P, Steerneman P,
Merckelbach H, and Meesters C. The role of parental fearfulness and modeling in
children's fear. Behaviour Research and Therapy 1996; 34: 265−268.
115.
Masi G, Favilla L, Mucci M,
Millepiedi S. Panic disorder in clinically-referred children and adolescents.
Child Psychiatry and Human Development 2000; 31: 139−151.
116.
Francis G, Last CG, Strauss CC.
Expression of separation anxiety disorder: The roles of age and gender. Child Psychiatry
and Human Development 1987; 18: 82−89.
117.
Ollendick TH. Panic disorder in
children and adolescents: New developments, new directions. Journal of Clinical
Child Psychology 1998; 27: 234−245.
118.
Diler RS, Birmaher B, Brent DA,
Axelson DA, Firinciogullari S, Chiapetta L. Phenomenology of panic disorder in
youth. Depression and Anxiety 2004; 20: 39−43.
119.
Kashdan TB, Herbet JD. Social
anxiety disorder in childhood and adolescence: Current status and future
directions. Clinical Child and Family Psychology Review 2001; 4: 37−61.
120.
Kronenberger WG, Meyer RG. The
child clinician's handbook, 2nd ed.
121.
Masi G, Mucci M, Nicoletta B,
Bertini N, Milantoni L, and Arcangeli FA. Naturalistic study of referred
children and adolescents with obsessive–compulsive disorder. Journal of the
American Academy of Child and Adolescent Psychiatry 2005; 41: 1431−1438.
122.
Snider
LA, Swedo SE. Paediatric obsessive– compulsive
disorder. Journal of the American Medical Association 2000; 284: 3104−3106.
123.
Freeman JB, Garcia AM, Fucci C,
Karitani M, Miller L, Leonard HL. Family-based treatment of early-onset
obsessive–compulsive disorder. Journal of Child and Adolescent Psychopharmacology
2003; 13 (1), S 71−S80.
124.
Yule W. Post-traumatic stress
disorder in children and adolescents. International Review of Psychiatry 2001;
13: 194−200.
125.
Taghavi MR, Dalgleish T, Moradi
AR, Neshat-Doost HT, Yule W. Selective
processing of negative emotional information in children and adolescents
with generalized anxiety disorder. British Journal of Clinical Psychology 2003; 42: 221−230.
126.
127.
Beck AT. Cognitive therapy and
the emotional disorders. International University Press; New York 1976.
128.
Hoehn-Saric R, McLeod DR.
Anxiety and arousal: Physiological changes and their perception. Journal of
Affective Disorders 2000; 61: 217−224.
129.
Alfano CA, Ginsburg GS, Kingery
JN. Sleep related problems among children and adolescents with anxiety
disorders. Journal of the American Academy of Child and Adolescent Psychiatry
2007; 46: 224−232.
130.
Storch EA, Merlo LJ.
Obsessive–compulsive disorder: Strategies for using CBT and pharmacotherapy.
Journal of Family Practice 2006; 55: 329−333.
131.
Sally Roach. Introductory Clinical Pharmacology, 7th
edition.
132.
Fuchs E, Flugge G. Experimental
animal models for the simulation of depression and anxiety. Dialogues Clin
Neurosci 2006; 8:323-33.
133.
Vogel GH. Drug Discovery and Evaluation Pharmacological
Assays 2nd revised updated and Enlarged Edition. Springer-Verlag Berlin Heidelberg 2002.
134.
Shekhar A, McCann UD, Meany MJ.
Summary of a National institute of mental Health workshop: Developing animal
models of anxiety disorders. Psychopharmacology 2001; 157:327-39.
135.
Goa KL, Ward A. Buspirone: a
preliminary review of its pharmacological properties and therapeutic efficacy
as an anxiolytic drug Indian Journal of Pharmacology 1986; 32:114-29.
136.
Lister RG. The use of a
plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92:180-185.
137.
Griebel G.
5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders:
more than 30 years of research. Pharmacol Ther 1995; 65:319-95.
138.
Rodgers
RJ, Cao BJ, Dalvi A, et al. Animal models of anxiety:
an ethological perspective. Braz J Med Biol Res 1997; 30:289-304.
139.
Weiss SM, Lightowler S,
Stanhope KJ, Kennett GA, Dourish CT. Measurement of anxiety in transgenic mice.
Rev Neurosci 2000; 11:59-74.
140.
Hogg S. A review of the
validity and variability of the elevated plus - maze as an animal model of
anxiety. Pharmacol Biochem Behav 1996; 54:21-30.
141.
Rodger RJ, Johnson NJT. Factor
analysis of spatiotemporal and ethological measures in the murine elevated
plus-maze test of anxiety. Pharmacol Biochem Behav 1995; 52:297-303.
142.
143.
Kelley AE. Locomotor activity
and exploration. In Sahgal A, Behavioural Neuroscience. A Practical Approach.
Vol II. Oxford, UK: IRL Press; 1993: p.1-21.
144.
File SE. Animal models for
predicting clinical efficacy of anxiolytic: social behavior. Neuropsychobiol
1985; 13:55-62.
145.
146.
Davis M, Falls WA, Campeau S,
Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav
Brain Res 1993; 58:175-98.
147.
Blanchard RJ, Blanchard DC.
Affect and aggression: an animal model applied to human behavior. In: Blanchard
RJ,
148.
Griebel G, Blanchard DC, Jung
A, Blanchard RJ. A model of ant predator defense in Swiss-Webster mice: effects
of benzodiazepine receptor ligands with different intrinsic activities. Behav
Pharmacol 1995; 6:732-745.
149.
Blanchard DC, Griebel G, Blanchard
RJ. Mouse defensive behaviors: pharmacological and behavioral assays for
anxiety and panic. Neurosci Biobehav Rev 2001; 25:205-281.
150.
File SE, Gonzalez LE, and
Andrews N. Comparative study of pre and postsynaptic 5-HT1A receptor
modulation of anxiety in two ethological animal tests. J Neurosci 1996;
16:4810-4815.
151.
Ramboz
S, Oosting R, and Amara DA. Serotonin receptor 5HT-1A
knockout: an animal model of anxiety related disorder. Proc Natl Acad Sci 1998;
95:14476-14481.
152.
Stenzel-Poore
MP, Duncan JE, Rittenberg MB. CFR overproduction in
transgenic mice: behavioral and immune system modulation. Ann NY Acad Sci 1996;
780:36-48.
153.
Crestani F, Lorez M, Baer K.
Decreased GABA-A receptor clustering results in enhanced anxiety and a bias for
threat cues. Nat Neurosci 1999; 2:8339.
154.
Finn DA,
155.
Belzung C, Griebel G. Measuring
normal and pathological anxiety- like behavior in mice: a review. Behav Brain
Res 2001; 125:141-142.
156.
157.
Goto SH, Conceicao IM, Ribeiro
RA, Frussa Filho R. Comparison of anxiety measured in the elevated plus maze,
open arms and social interaction tests between spontaneously hypertensive rats
and Wistar EPM-1 rats. Braz J Med Biol Res 1993; 26:965-969.
158.
Chaouloff F, Castanon N,
Mormede P. Paradoxical differences in animal models of anxiety among the roman
rat lines. Neurosci Lett 1994; 182:217-221.
159.
Colombo
G, Agabio R, Lobina C. Sardinian alcohol-preferring
rats a genetic animal model of anxiety. Physiol Behav 1995; 57:1181-1185.
160.
Liebsch G, Montowski A,
Holsboer F. behavioral profiles of two Wistar lines selectively bred for high
or low anxiety-related behavior. Behave Brain Res 1998; 94:301-310.
161.
Harborne JB. Phytochemical
methods, a guide to modern techniques of plant analysis.3rd edition.
Chapmam & Hall Publicatio; London (UK) 1998: p.06.
162.
Kokate CK, Purohit AP, Gokhale
SB. Pharmacognosy. 24th ed. Nirali Prakashan Pune; 2003. p.149-153.
163.
Harborne JB. Phytochemical
methods, a guide to modern techniques of plant analysis.3rd
edition.; Springer (India) Private Limited New Delhi 1998: p.09.
164.
Kokate CK, Practical Pharmacognosy, 4th Ed (Reprint) Vallabh
Prakashan; Delhi 1996:107-111.
165.
Khandelwal KR. Practical Pharmacognosy techniques and
experiments. 2nd edition Pune, Nirali Prakashan 2000; p.149-156.
166.
OECD/OCDE guidelines 425 for testing of chemicals,
acute oral toxicity up-and-down- procedure(UDP) along with the conventional
LD50 test and the fixed dose procedure (FDP), OECD test guidelines 420 and 423.
Adopted 3rd October 2008; Available from: http://www.oecd.org
167.
Hogg SA. Review of the validity
and Variability of the elevated plus-maze as an animal model of anxiety.
Pharmacol Biochem Behav 1996; 54: 21-30.
168.
Pellow S, File SE. Anxiolytic
and axiogenic drug effects on exploratory activity in an elevated plus-maze a
novel test of anxiety in the rat. Pharmacol Biochem Behav 1986; 24: 525-529.
169.
Kulkarni SK. Handbook of
Experimental pharmacology. 3rd
edition.New Delhi; Vallabha Prakashan 1999: p.135.
170.
Rodgers RJ, Johnson NJT.
Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in
mice. Pharmacol Biochem Behav
1998; 59: 221-232.
171.
Soman
I, Mengi SA, Kasture SB. Effects of leaves of Butuea
frondosa on stress, anxiety and cognition in rats. J Pharmacol Biochem Behav
2004; 79:11-16.
172.
Zanoli P, Avallone R, Baraldi
M. Behavioral characterization of the flavonoids apigenin and chrysin.
Fitoterapia 2000; 71: S117-S123.
173.
Maribel HR. Antidepressant and
anxiolytic effects of hydroalcoholic extract from Salvia elegans. J
Ethnopharmacol 2006; 107: 53-58.
174.
Crawley J, Goodwin FK.
Preliminary report of a simple animal behavior model for the anxiolytic effects
of benzodiazepines. Pharmacol Biochem Behav 1980; 13: 167-170.
175.
Bhatacharya SK, Satyan KS.
Experimental methods for evaluation of psychotropic agents in rodents: anti
anxiety agents. Indian J Exp Biol 1997;35:575.
176.
Hellion-Ibarrola
MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzanoa M,
Tortoriello J, Fernandez S, Wasowski C, Marder M, De Limad TCM, Mora S. The
anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. Journal
of Ethnopharmacology 2006; 105: 400–408.
177.
File SE, Seth P. A review of 25
years of the social interaction test. European Journal of Pharmacology 2003;
463: 35-53.
Comments
Post a Comment